PD-L1 Inhibitors in NSCLC: Precision, Personalization, and Practice Impact
November 5, 2026
5:30 pm
Upcoming
Optimizing Weight Loss: Differentiating GLP-1 Therapies in Personalized Obesity Management
November 5, 2026
6:00 pm
Upcoming
The Landscape of Anticoagulation: Evidence, Emerging Therapies, and Management Strategies in Atrial Fibrillation and Secondary Stroke Prevention
November 7, 2026
5:30 pm
Upcoming
PD-L1 Inhibitors in NSCLC: Precision, Personalization, and Practice Impact
November 10, 2026
5:30 pm
Upcoming
Beyond the Data: Translating CLL Evidence into Pharmacist-Led Recommendations
November 11, 2026
5:30 pm
Upcoming
Beyond the Data: Translating CLL Evidence into Pharmacist-Led Recommendations
November 12, 2026
5:30 pm
Upcoming
Beyond the Data: Translating CLL Evidence into Pharmacist-Led Recommendations
December 2, 2026
5:30 pm
Upcoming
Beyond the Data: Translating CLL Evidence into Pharmacist-Led Recommendations
December 3, 2026
5:30 pm
Upcoming
Beyond the Data: Translating CLL Evidence into Pharmacist-Led Recommendations
December 16, 2026
5:30 pm
Upcoming